The Mydriasis Market Research Report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted Mydriasis market Size from 2017 to 2030 segmented by seven major markets.
The report provides a detailed current Mydriasis treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Mydriasis is the dilation of the pupil, which may be due to a non-physiological cause such as disease, trauma, drug usage, or physiological pupillary response. A mydriatic is an agent that induces dilation of the pupil; it is routinely used to aid examination of the retina and other deep structures of the eye. In general medical practice, the most frequent indication for pupil dilation is in the screening of diabetic retinopathy followed by macular degeneration.
Medications such as phenylephrine, tropicamide, cyclopentolate, atropine are currently used as mydriatic agents. New therapies such as OMS302 and others have been carried out to testing the efficacy and safety profile of this new formulation are warranted to provide more evidence that supports its use.
A lot of research on mydriatics is focused on the fixed-dose combination of mydriatics with other mydriatics, mydriatics with cycloplegics, mydriatics with anesthetics, and administration by intracameral injections and eye inserts to facilitate pupil dilation during cataract surgeries.
Mydriasis Market Key Facts
-
The total diagnosed prevalent population of Mydriasis in the 7MM countries was estimated to be 3.58 million in 2017.
-
As cataract usually affects the aged more than the young, the age-specific cases show peak distribution between 70 and 79 years. In the United States, 1.39 million procedures were performed within this age group (70–79) in 2017, which are expected to rise by 2030.
-
Among the European countries, France along with Germany had the highest number of cataract surgeries with approximately 0.87 million procedures each in 2017
-
Among the European 5 countries, Spain had the lowest number of cases with 0.35 million procedures in 2017.
Get FREE sample copy at: https://www.delveinsight.com/sample-request/mydriasis-market
Key Benefits of Mydriasis Market Report
-
The market report provides an in-depth analysis of Mydriasis Market Size, Share, Trend, and Epidemiology Forecast till 2030 in the seven major markets (i.e. the United States, EU5 (Germany, Italy, Spain, France, and the UK) and Japan.
-
The report will help in developing business strategies by understanding the Mydriasis Market Trends, recent developments, key players, and future market competition that will shape and drive the market growth in the upcoming years.
-
The market report covers the Mydriasis current treatment practices, emerging drugs, market share of the individual therapies in the seven major markets.
-
The report provides a detailed assessment of the Mydriasis market in terms of market drivers & barriers, unmet needs, market opportunities, patient population, detailed comparative analysis of pipeline products including clinical and non-clinical stage products, and other factors.
Mydriasis Market
The market size of Mydriasis shall increase during the forecast period, owing to the launch of upcoming therapies.
The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Mydriasis market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.
The report gives a thorough detail of the Mydriasis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Mydriasis Epidemiology
The epidemiology section covers insights about the historical and current Mydriasis patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Mydriasis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Mydriasis market or expected to get launched in the market during the study period. The analysis covers Mydriasis market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The report also covers the Mydriasis Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.
Some of the companies have recently shifted their focus on this indication and the launch of expected therapies for Mydriasis is expected to create a significant impact on the market size during the forecast period.
Key companies in the Mydriasis market include:
-
Théa Laboratories
-
Omeros Corporation
-
Ocuphire Pharma
And many others.
Mydriasis Therapies covered in the report include:
-
Mydrane
-
Mydriasert
-
OMIDRIA
-
Nyxol
And others.
Request for Sample @ Mydriasis Therapeutics Market Assessment
Table of Content
1. Key Insights
2. Executive Summary
3. Mydriasis Competitive Intelligence Analysis
4. Mydriasis Market Overview at a Glance
5. Mydriasis Disease Background and Overview
6. Mydriasis Patient Journey
7. Mydriasis Epidemiology and Patient Population
8. Mydriasis Treatment Algorithm, Current Treatment, and Medical Practices
9. Mydriasis Unmet Needs
10. Key Endpoints of Mydriasis Treatment
11. Mydriasis Marketed Products
12. Mydriasis Emerging Therapies
13. Mydriasis Seven Major Market Analysis
14. Attribute Analysis
15. Mydriasis Market Outlook (7 major markets)
16. Mydriasis Access and Reimbursement Overview
17. KOL Views on the Mydriasis Market.
18. Mydriasis Market Drivers
19. Mydriasis Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.
Get FREE sample copy at: https://www.delveinsight.com/sample-request/mydriasis-market
Latest Reports By DelveInsight
DelveInsight’s “Dementia with Diabetes Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Dementia with Diabetes market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
Corneal Endothelial Dystrophy Market
DelveInsight’s “Corneal Endothelial Dystrophy Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Corneal Endothelial Dystrophy market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/